Canada's most authoritative and exciting grocery b2b publication
Industry NewsGSK Consumer Healthcare demerger, company renamed ‘Haleon’

GSK Consumer Healthcare demerger, company renamed ‘Haleon’

hero-4-1600-900-2232335

GSK’s Consumer Healthcare business is on track to become an independent company through a proposed demerger from GSK in mid-2022. The new business will be named Haleon and will offer a portfolio of global brands, including Sensodyne, Voltaren, Panadol and Centrum.

Follow us:









Recent Issues

Related Articles